Quince Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -11.91 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
0.4989 | 4.82 | -89.65% |
|
|
| P/FCF |
|
-2.41 | 60.98 | -103.95% |
|
|
| Ev/Ebitda |
|
-1.46 | -22.12 | -93.4% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-1.92 | 68.75 | -102.8% |
|
|
| E/P |
|
-0.7069 | 0.0178 | -4077.23% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.83 | -100% | 0 | 0% |
| ROE |
|
-36.89 | 9.61 | -483.99% |
|
|
| ROA |
|
-17.42 | 0.3359 | -5284.9% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-28.96 | 15.33 | -288.91% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5548 | -3.67 | -84.87% | -0.2269 | 144.57% |
| Nеt Debt/Ebitda |
|
0.2853 | -3.44 | -108.3% |
|
|
| Debt/Ratio |
|
0.0749 | 0.1972 | -62.02% |
|
|
| Debt/Equity |
|
34.33 | 1.65 | 1985.3% |
|
|
| Debt/Net Income |
|
-0.4299 | 10.31 | -104.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
0 | -56.89 | -100% |
| Growth impulse Ebitda 5 years |
|
-34.23 | -64.81 | -47.18% |
| Growth impulse Net Income 5 years |
|
-14.7 | -58.33 | -74.8% |
| Growth impulse FCF 5 years |
|
-44.64 | -47 | -5.02% |
| Growth impulse EPS 5 years |
|
-56.4 | -32.41 | 74.02% |
IP Score
2.35/10
